The investment round was led by Mercia Ventures with participation from Deepbridge Capital and Guillaume d'Eyssautier.
"With the increasing demand from semiconductor businesses for 'second-sourcing' to unlock new markets and address evolving requirements, Thalia stands as the ideal strategic partner. Our AMALIA platform provides a proven solution that enables them to, for example, quickly and efficiently migrate existing designs into the sub-20 nanometre range to align with industry demand for better performance and power consumption."
The Exeter-based ecommerce intelligence platform has raised £1.1m in a round led by Mercia Ventures alongside angel backing.
"At Distil, we are passionate about the power of data. It is the lifeblood of any business, shaping the landscape of industries around us. However, to truly harness its potential and transform it into a strategic asset, the way we approach and manage data must evolve. This is the driving force behind Distil.ai. Our mission is simple – if you want your data to guide your strategy, empower your marketing, and boost your profits, it’s time to start ‘Distiling’ it. We’ve filled Distil with powerful algorithms to provide a clear view of your business’s performance. With the support of our partners in this funding round, we’re set to accelerate the shift towards a more insightful and efficient future."
The Cambridge-based synthetic gene provider raised the capital from Mercia Ventures to expand operations and develop its DNA synthesis platform.
"We are delighted to have closed this latest round of funding with Mercia, which provides further validation of Camena’s approach. The ability to read, write and manipulate DNA is the foundation of the synthetic biology value chain, yet developments in DNA synthesis have not kept pace with DNA sequencing and editing capabilities. Camena’s gSynth platform is revolutionising the DNA synthesis market by unlocking access to genes and accelerating discovery pipelines. As the focus on sustainability and supply-chain security become more acute, Camena is leading the way with a green synthesis technology and is already well positioned to serve this burgeoning market. The invention of next-generation DNA sequencing technologies transformed our ability to ‘read’ DNA. Our goal is to enable our customers to ‘write’ DNA with the same confidence and ease."
The investment round was led by YFM Equity Partners with participation from Mercia and Foresight Group.
"We’re proud of what we’ve achieved so far and are very grateful for the support of our clients and partners, but it feels like we’re just getting started."
The funding was provided by the MEIF Proof of Concept and Early Stage Fund alongside Mercia's EIS funds.
"We are excited about this new chapter at OneUp Sales. Our growth and this successful fundraising round validate the impact we’re having on hundreds of sales teams around the world. With the support of our investors, we are well prepared to pursue our vision and deliver even greater functionality to our clients; our upcoming commission management tool is set to be a gamechanger for finance and sales teams everywhere."
.png)